Literature DB >> 35982203

Characterizing fatigue phenotypes with other symptoms and clinically relevant outcomes among people with multiple sclerosis.

Matthew Plow1, Douglas D Gunzler2, Julia H C Chang3.   

Abstract

PURPOSE: Fatigue is a common symptom of multiple sclerosis (MS) and can adversely affect all aspect of quality of life. The etiology of fatigue remains unclear, and its treatments are suboptimal. Characterizing the phenotypes of fatigued persons with MS may help advance research on fatigue's etiology and identify ways to personalize fatigue interventions to improve quality of life. The purpose of this study was to identify fatigue phenotypes; examine phenotype stability overtime; and characterize phenotypes by health and function, social and environmental determinants, psychosocial factors, and engagement in healthy behaviors.
METHODS: We conducted a longitudinal study over a 3-month period with 289 fatigued participants with MS. To identify fatigue phenotypes and determine transition probabilities, we used latent profile and transition analyses with valid self-report measures of mental and physical fatigue severity, the mental and physical impact of fatigue, depression, anxiety, and sleep quality. We used ANOVAs and effect sizes to characterize differences among phenotypes.
RESULTS: The best fitting model included six subgroups of participants: Mild Phenotype, Mild-to-Moderate Phenotype, Moderate-to-Severe Phenotype, Severe Phenotype, Fatigue-dominant Phenotype, and Mental Health-dominant Phenotype. The transition analysis indicated that phenotypic membership was highly stable. Variables with a large eta squared effect size included environmental barriers, self-efficacy, and fatigue catastrophizing.
CONCLUSION: These results indicate that the magnitude of fatigue experienced may be more important to consider than the type of fatigue when characterizing fatigue phenotypes. Future research should explore whether tailoring interventions to environmental barriers, self-efficacy, and fatigue catastrophizing reduce the likelihood of transitioning to a more severe phenotype.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Depression; Fatigue; Mental Health; Multiple Sclerosis

Year:  2022        PMID: 35982203     DOI: 10.1007/s11136-022-03204-0

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  56 in total

1.  Factors related to employment status changes in individuals with multiple sclerosis.

Authors:  Megan M Smith; Peter A Arnett
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

2.  The meaning of fatigue for women with multiple sclerosis.

Authors:  Malin Olsson; Jan Lexell; Siv Söderberg
Journal:  J Adv Nurs       Date:  2005-01       Impact factor: 3.187

Review 3.  The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis.

Authors:  Philippa Miller; Andrew Soundy
Journal:  J Neurol Sci       Date:  2017-08-12       Impact factor: 3.181

4.  Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis.

Authors:  Scott Rooney; Les Wood; Fiona Moffat; Lorna Paul
Journal:  Mult Scler Relat Disord       Date:  2019-01-03       Impact factor: 4.339

5.  Fatigue and social impairment in multiple sclerosis: the role of patients' cognitive and behavioral responses to their symptoms.

Authors:  Tanaya N Skerrett; Rona Moss-Morris
Journal:  J Psychosom Res       Date:  2006-11       Impact factor: 3.006

Review 6.  Fatigue self-management education in persons with disease-related fatigue: A comprehensive review of the effectiveness on fatigue and quality of life.

Authors:  Ruth Hersche; Katharina Roser; Andrea Weise; Gisela Michel; Marco Barbero
Journal:  Patient Educ Couns       Date:  2021-09-14

7.  Which behavioural and exercise interventions targeting fatigue show the most promise in multiple sclerosis? A systematic review with narrative synthesis and meta-analysis.

Authors:  Rona Moss-Morris; Anthony M Harrison; Reza Safari; Sam Norton; Marietta L van der Linden; Federica Picariello; Sarah Thomas; Claire White; Tom Mercer
Journal:  Behav Res Ther       Date:  2019-08-28

Review 8.  Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature.

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  J Clin Neurosci       Date:  2018-03-30       Impact factor: 1.961

Review 9.  Occupational Therapy in Fatigue Management in Multiple Sclerosis: An Umbrella Review.

Authors:  Angela Salomè; Tullia Sasso D'Elia; Giorgia Franchini; Valter Santilli; Teresa Paolucci
Journal:  Mult Scler Int       Date:  2019-03-21

10.  Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.

Authors:  Bardia Nourbakhsh; Nisha Revirajan; Bridget Morris; Christian Cordano; Jennifer Creasman; Michael Manguinao; Kristen Krysko; Alice Rutatangwa; Caroline Auvray; Salman Aljarallah; Chengshi Jin; Ellen Mowry; Charles McCulloch; Emmanuelle Waubant
Journal:  Lancet Neurol       Date:  2020-11-23       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.